1 results about "Amylobarbitone sodium" patented technology

The application provides a composite biomaterial loaded with multi-mode reprogramming therapeutic agents, a preparation method thereof and application thereof in treating osteoarthritis, and belongs to the technical field of biological medical materials, drug delivery, regenerative medicine and epigenetics. The composite biomaterial comprises sodium isoamyl barbital, an epigenetic reprogramming small molecule VC6TF and a lipid nanoparticle encapsulating a reprogramming factor mRNA. The composite material has a precise construction idea and a systematic in-vivo and in-vitro performance and safety evaluation system, so that it can treat osteoarthritis by precisely reversing the epigenetic age of joint cells.